Cosmos Health Enters into Binding Letter of Intent for the Acquisition of Docpharm GmbH., an Established German Pharmaceutical Distributor; Expected to Boost Our Annual Revenue by Approximately Euro32M, or 70%, by the End of 2025 vs FY 2022.

May 25, 2023